| According to the 2021 annual report of Huluwa Pharmaceutical, the company will achieve an operating income of 35 billion yuan in 2021, a year-on-year increase of 153%; and a net profit attributable to shareholders of the listed company of 71379 million yu.
The rapid growth of children'spatent medicines The 2020 edition of "Chinese Pharmacopoeia (Part I)" includes a total of 1,457 Chinese patent medicines and single-flavor preparations, and the number of preparations available to children is 23 Among them, pediatric medicines can be divided into 17 kinds of granules, 13 kinds of oral liquids, 8 kinds of syrups, 8 kinds of pills, 6 kinds of tablets, 3 kinds of powders, 2 kinds of capsules and 1 kind of liniment according to the dosage form; Indications are mainly cough and asthma, indigestion, cold and flu, fever, abdominal distension and abdominal pa.
For a long time, the number of special medicines for children in China is seriously insufficie.
During the period from January 2021 to June 2022, the core raw materials of Xiaoer Feirekechuan Granules included 6 varieties that increased, accounting for 554%, 3 varieties that decreased, accounting for 227%, and 2 varieties that were flat, accounting for 11
|
